Conestoga Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,130
| Closed | -$321K | – | 132 |
|
|
2024
Q1 | $321K | Hold |
1,130
| – | – | ﹤0.01% | 123 |
|
|
2023
Q4 | $325K | Hold |
1,130
| – | – | ﹤0.01% | 124 |
|
|
2023
Q3 | $304K | Hold |
1,130
| – | – | 0.01% | 119 |
|
|
2023
Q2 | $251K | Hold |
1,130
| – | – | ﹤0.01% | 126 |
|
|
2023
Q1 | $273K | Sell |
1,130
-200
| -15% | -$49.1K | ﹤0.01% | 125 |
|
|
2022
Q4 | $349K | Hold |
1,330
| – | – | 0.01% | 116 |
|
|
2022
Q3 | $300K | Hold |
1,330
| – | – | 0.01% | 125 |
|
|
2022
Q2 | $324K | Hold |
1,330
| – | – | 0.01% | 128 |
|
|
2022
Q1 | $322K | Hold |
1,330
| – | – | ﹤0.01% | 130 |
|
|
2021
Q4 | $299K | Hold |
1,330
| – | – | ﹤0.01% | 136 |
|
|
2021
Q3 | $283K | Hold |
1,330
| – | – | ﹤0.01% | 138 |
|
|
2021
Q2 | $324K | Hold |
1,330
| – | – | ﹤0.01% | 129 |
|
|
2021
Q1 | $331K | Hold |
1,330
| – | – | 0.01% | 125 |
|
|
2020
Q4 | $306K | Hold |
1,330
| – | – | ﹤0.01% | 133 |
|
|
2020
Q3 | $338K | Hold |
1,330
| – | – | 0.01% | 128 |
|
|
2020
Q2 | $314K | Hold |
1,330
| – | – | 0.01% | 130 |
|
|
2020
Q1 | $270K | Hold |
1,330
| – | – | 0.01% | 127 |
|
|
2019
Q4 | $321K | Hold |
1,330
| – | – | 0.01% | 132 |
|
|
2019
Q3 | $257K | Hold |
1,330
| – | – | 0.01% | 133 |
|
|
2019
Q2 | $245K | Hold |
1,330
| – | – | 0.01% | 137 |
|
|
2019
Q1 | $253K | Hold |
1,330
| – | – | 0.01% | 135 |
|
|
2018
Q4 | $259K | Hold |
1,330
| – | – | 0.01% | 114 |
|
|
2018
Q3 | $276K | Hold |
1,330
| – | – | 0.01% | 114 |
|
|
2018
Q2 | $246K | Hold |
1,330
| – | – | 0.01% | 120 |
|
|
2018
Q1 | $227K | Hold |
1,330
| – | – | 0.01% | 117 |
|
|
2017
Q4 | $231K | Hold |
1,330
| – | – | 0.01% | 117 |
|
|
2017
Q3 | $248K | Hold |
1,330
| – | – | 0.01% | 109 |
|
|
2017
Q2 | $229K | Hold |
1,330
| – | – | 0.01% | 110 |
|
|
2017
Q1 | $218K | Buy |
+1,330
| New | +$221K | 0.01% | 107 |
|
|
2016
Q4 | – | Sell |
-1,330
| Closed | -$222K | – | 118 |
|
|
2016
Q3 | $222K | Hold |
1,330
| – | – | 0.02% | 106 |
|
|
2016
Q2 | $202K | Sell |
1,330
-200
| -13% | -$31.1K | 0.01% | 115 |
|
|
2016
Q1 | $229K | Hold |
1,530
| – | – | 0.02% | 103 |
|
|
2015
Q4 | $248K | Hold |
1,530
| – | – | 0.02% | 96 |
|
|
2015
Q3 | $212K | Hold |
1,530
| – | – | 0.02% | 104 |
|
|
2015
Q2 | $235K | Hold |
1,530
| – | – | 0.02% | 104 |
|
|
2015
Q1 | $245K | Hold |
1,530
| – | – | 0.02% | 104 |
|
|
2014
Q4 | $244K | Hold |
1,530
| – | – | 0.02% | 106 |
|
|
2014
Q3 | $215K | Buy |
+1,530
| New | +$200K | 0.02% | 106 |
|
|
2014
Q2 | – | Sell |
-1,630
| Closed | -$201K | – | 132 |
|
|
2014
Q1 | $201K | Buy |
+1,630
| New | +$198K | 0.01% | 127 |
|
Other funds holding AMGN
Conestoga Capital Advisors's AMGN Position: Q2 2024 in Review
Conestoga Capital Advisors sold out of Amgen (AMGN) in Q2 2024, closing a stake of 1,130 shares — an estimated $321K sold.
Conestoga Capital Advisors first reported a position in AMGN in Q1 2014 and held it in 39 quarters. The position peaked at $349K in Q4 2022. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Conestoga Capital Advisors reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
- Conestoga Capital Advisors sold 1,130 Amgen shares in Q2 2024, an estimated $321K.
- Conestoga Capital Advisors first reported a position in Amgen in Q1 2014 and held it in 39 quarters.
- Conestoga Capital Advisors's Amgen position peaked at $349K in Q4 2022.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Conestoga Capital Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.